chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented to Hospital, at the urgency of his oncologist.  The patient reported dyspnea for several weeks.  In ED oxygen saturation at 77% RA, and he then tested positive for Covid-19.  He was anemic, thrombocytopenic, mildly elevated troponin, and signs of renal failure.  CXR showed interstitial and mild groundglass opacities concerning for pulmonary edema.  CT angiogram of chest showed no PE, did reveal patchy interstitial and groundglass airspace disease.  Patient was placed on BiPAP, he was found to be occult blood positive, and was transfused.  Patient was transitioned to comfort care and expired on 09/28/2021.
This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), MUSCLE DISCOMFORT (Muscle discomfort in her arm, legs, and abdominal area), PAIN (with each vaccination she would feel achy), MUSCULAR WEAKNESS (Muscles would be sore and weak) and MYALGIA (Muscles would be sore and weak) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. Concurrent medical conditions included Spinal stenosis, Thyroid disorder, Blood pressure high (Started in patient's late 40s-50s), Hypothyroidism (Started in patient's mid 30s), Sneezing (Seasonal allergy), Drug allergy (Lisinopril, cannot have any prils), Cane user, Walker user (Rollator walker depending on the day started either in 2017 or 2018), Persistent cough since 2000, Foot drop (Left), Heat intolerance (heat affect her nerves and muscles, utilizes shade and a cooling rag), Arthritis multiple joint (especially hands and knuckles, comes on gradually, does not have joint pain, began 2-3 years ago, weather affects it), Tiredness (Increases at the end of the day), Urinary frequency and Seasonal allergy. Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN, LEVOTHYROXINE, DULOXETINE, ASPIRIN [ACETYLSALICYLIC ACID] and OCRELIZUMAB (OCREVUS) for an unknown indication. On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness), MUSCLE DISCOMFORT (Muscle discomfort in her arm, legs, and abdominal area), PAIN (with each vaccination she would feel achy), MUSCULAR WEAKNESS (Muscles would be sore and weak) and MYALGIA (Muscles would be sore and weak). At the time of the report, ASTHENIA (Weakness), MUSCLE DISCOMFORT (Muscle discomfort in her arm, legs, and abdominal area), PAIN (with each vaccination she would feel achy), MUSCULAR WEAKNESS (Muscles would be sore and weak) and MYALGIA (Muscles would be sore and weak) outcome was unknown. The patient started with Moderna vaccine therapy on 06-Apr-2021 and experienced adverse events with COVID vaccines and boosters. Patient was taking blood pressure medication and thyroid medication. No treatment medications were provided by the reporter. Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2022: Live follow-up with non-significant information was received.
Swollen face; Red face-like rash on face; Swollen bloody sores inside mouth cheeks, on gums, tongue, throat; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) in the left arm on 17Mar2021 at 12:00 (at the age of 49-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) in the left arm on 08Apr2021 at 15:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune diseases, COVID-19, allergy to latex and sulfa. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received codeine (MANUFACTURER UNKNOWN) and  morphine (MANUFACTURER UNKNOWN) and experienced allergy to both the drugs. On 17Mar2021 at 22:00, the patient experienced swollen face, red face which was like rash on face, swollen and bloody sores inside mouth cheeks, on gums, tongue and throat. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with BENADRYL every 4 hours around the clock. The clinical outcome of the events swollen face, red face which was like rash on face swollen and bloody sores inside mouth cheeks, on gums, tongue, throat were resolved with  lasting effects on an unknown date in 2021 at the time of this report.   No follow-up attempts are needed. No further information is expected.
have gotten the shot twice and I still get small patches on my butt\ suspected vaccination failure; still get small patches on my butt; small patches on my butt; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and patchy rash. On an unknown date, the outcome of the vaccination failure, shingles and patchy rash were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and patchy rash to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient stated he/she had Shingles shot twice and still got small patches on butt. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming herpes zoster were unknown at the time of reporting.
Narrative: Pt COVID positive despite 3 doses of COVID vaccine. 7/4/52022-Patient presents to emergency department complaint of shortness of breath since onset of a cough this past Thursday Patient indicates he also has had nasal congestion and a little bit of sore throat and a slight headache. He indicates gradually increasing shortness of breath without any chest pain since this past Thursday. He has COPD. Pt admitted to medical floor 7/4/2022- 7/9/2022. Pt had 5d treatment with Remdesivir. Medical treatment: COVID-19 with Acute Hypoxic Respiratory Failure- Completed dexamethasone 6mg daily; Day #6 - Completed Remdesivir; Day #5 - Home O2 evaluation with no Home Oxygen needed - Tesselon perles PRN
arm is now swollen; arm is kind of swollen and there is a knot in there, a hard knot; Arm Itches; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 at the age of 65-year-old, via an unspecified route of administration on 04Mar2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated that she got the shot and her arm was kind of swollen and there was a knot in there, a hard knot, and the arm itches on 09Mar2021. She states that she noticed the swelling today, 09Mar2021. She has just been scratching it. The patient wanted to know if this was normal or a normal reaction. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
C/o severe RUQ pain since receiving immunization on 1-11-11 - much more intense today 1-14-11 temp 98.6 degrees F BP 138/86.
Mother noted blood in stool & child seemed in pain. Went to ER. Now child is fine.
Immediate reaction after the shot hight blood pressure , tachicardia, warmness in the arm neck and head on the same side at vaccination
Information has been received from a physician concerning a 5 year old male patient who on 19-AUG-2009, was vaccinated with the second dose of VARIVAX (Merck) (lot# 664717/0807Y) in the right thigh. On 20-AUG-2009, the patient experienced redness, swelling and warm to touch. At the time of the report the patient had recovered. It is unknown if the patient sought medical attention. This is one of two reports from the same source. Additional information is not expected.
10-06-2004 PM Child had fever, severe headache.  Vaccination site was swollen, hard, red and sore. 10-08-2004 Mom called this nurse and reported continued redness, swelling, and hard knot at injection site.  Reported that child did not move the left arm, complained of deep muscle ache radiating down left arm.  Referred to MD. 10-08-2004 Received phone call from MD's office that this child should not receive further Td injections.  Child is being placed on Keflex and prednisone for cellulitis reaction to vaccination.
after the first dose she experience side effect like hypersensitivity and pain arm as well and that's it.; after the first dose she experience side effect like hypersensitivity and pain arm as well and that's it.; This is a spontaneous report from a contactable consumer (herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 22Jun2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and medications were not reported. The patient experienced after the first dose she experience side effect like hypersensitivity and pain arm as well and that's it on Jun2021. Consumer stated, He told her guys would be able to tell her if she needs to go to the doctors about it or if she needs to like go to the hospital or not. The clinical outcome of the events was unknown.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Leg became swollen, warm. Area approx. 20 mm x 30 mm today and mild erythema and edema. Patient went to the Pediatric Urgent Care on 02/23/19. He was given prescriptions for Cephalexin, Prednisone and Baclofen .
covid arm........10 days after vaccine large red rash appeared ......also warm to touch.itchy
Mom phoned nurse triage because pt. temp up to 104 and not acting herself, no rash at site, moving extremities fine, came in 4/30/12.
Vesicular rash started that is all over the patient's body. She stated she noticed it in the morning 10/30/16 and that it had already begun to resolve. It was on her entire legs, back, stomach, and arms.
developed a sneezing episode; nose would run; This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (developed a sneezing episode) and RHINORRHOEA (nose would run) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SNEEZING (developed a sneezing episode) and RHINORRHOEA (nose would run). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, SNEEZING (developed a sneezing episode) and RHINORRHOEA (nose would run) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided.   This case was linked to MOD-2021-101008 (Patient Link).
Post vax, the pt experienced 2 weeks period of severe neck soreness without any trauma or illness.
Pt fainted after receiving flu shot. Pt request water. After drinking water, pt felt better but went to ER as a precaution.
Vaccine was expired, no temperature excursions occurred and Moderna determined the vial "maintained the activity necessary to protect against the SARS CoV-2 virus at the time of administration". Patient reported no adverse reactions.
COVID nasal swab - resulted positive for Covid on 6/10/21.  Last nasal swab was documented at 5/10/21 with a negative result. Patient is currently still in hospital and duration of hospitalization is pending.
pt recvd vax; devel rash; f/u md reported that pt had been in contact w/ chicken pox & devel full blown chicken pox;
A few hours after the second dose, my ears started popping a lot. It was in both ears and there were 3 separate "events", each consisting of about 20 pops and lasting about 20 seconds, for about 60 seconds total of ear popping. The best way I can think of to describe it is as if there were a little earthquake happening in my ears. It wasn't painful. I don't know if it was related to my second vaccine dose, but it's never happened before and hasn't happened since.
right hand shoulder had inflammation; was unable to move my hand; extreme pain with any movement of my hand/horrible pain while moving my arm; stiffness and horrible pain while moving my arm.; Very tiny rash on my right risk; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 27Mar2021 at 14:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, high cholesterol, asthma, neck and shoulder pain and environmental allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and lisinopril (MANUFACTURER UNKNOWN), all for unknown indications on unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 11:00, Monday morning, the patient's right hand shoulder had inflammation and she was unable to move her hand. There was an extreme pain with any movement of hand. The patient also reported that she had a sore neck (right side) and sore shoulder (right side) for weeks before the vaccine. She slept on her right side Sunday night and Monday morning woke up with this stiffness and horrible pain while moving her arm. She was much better after physical therapy on Tuesday 30Mar2021. The patient went to orthopedic surgeon on 01Apr2021 (thu) and doctor gave a cortisone shot on her right hand. She was much better now with her right shoulder and didn't had any pain while moving it. She also had a "very tiny rash on my right risk" which was gone now. The patient reported that she hopes she can get her scheduled second shot on 17Apr2021. She also reported that she doesn't know if the shot triggered this inflammation and pain. Events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events and included treatment with physical therapy on Tuesday, 30Mar2021 and Cortisone shot by Orthopedic Surgeon on 01Apr2021. The clinical outcome of the events right hand shoulder had inflammation, unable to move her hand, extreme pain with any movement of hand, stiffness and horrible pain while moving her arm and very tiny rash on right risk was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Headache; Chills; Mild fever; Muscle pain; Injection site swelling; Back pain; This is a spontaneous report from a contactable consumer (the patient).   A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: solution for injection, Batch/Lot number and expiration date were not reported) via an unspecified route of administration, in the left arm, on 27Jul2021 09:30 (age at vaccination was 42-year-old), as a single dose, for COVID-19 immunization. The patient's medical history included diabetes. Patient previously received aspirin and ibuprofen and experienced drug allergy. Concomitant medications included metformin, glipizide, rosuvastatin and vitamins. The patient's historical vaccine included first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Batch/Lot number and Expiration date were not reported) via an unspecified route of administration in the left arm on 06Jul2021 09:30 (age at vaccination was 42-year-old) as a single dose, for COVID-19 immunization. On 27Jul2021 at 22:00, the patient experienced the headache, chills, mild fever, muscle pain, injection site swelling and back pain. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior to vaccination. Patient was not tested for COVID-19, since the vaccination. Patient did not receive the any treatment for events. Outcome of the events was not recovered.    The lot number for the vaccine. (BNT162B2), was not provided and will be requested during follow-up.
Diagnosed with Type 1 diabetes, however the onset probably happened earlier, with 14 pound weight loss noted during the 2 to 3 weeks after the third course of HPV vaccination. Patient also had a large cyst (infection, not at the shot site) within days after the third vaccination (02/14/2011) which could indicate high blood sugar.
Started Friday night with pain. She is feeling dizzy and warm. Which started on 9/26/2010 after taking a shower. She has been putting ice and took Ibuprofen and EXCEDRIN. Rash on chest started Sat. night (9/25/10).
Patient got H1N1 vaccine in well developed right deltoid muscle at approx.8:45 am. No problems noted. No redness noted to arm. She left and went to P.E. Approx. 8:55 she returned with red non-raised rash to right arm. Rash located from wrist area to elbow only. No itching reported. C/o tingling to right hand. No other complaints. No resp. distress noted. Approx. 9am she started c/o of her right hand feeling numb and tingling in her throat. Resp. rate 18, pulse 108, BP 130/78. Respirations even and unlabored. School nurse was notified, office notified 911. Family noitified Epi immediately drawn up in preparation for administration when paramedics arrived 2-3 minutes post 911 call. We did not administer Epi or Benadryl, patient was not in any resp. distress. Paramedics did not administer any Epi or Benadryl. Paramedics told Father they did not feel like she needed to be transported by ambulance but that father should take her to be checked by MD. Child left with father in private car. She went to and saw Dr. Referred to Neurologist this afternoon.
Information has been received from a physician concerning a 2 month old female whose 4 yr old sister was vaccinated at 12 months of age with a dose of varicella virus vaccine live. In Nov 2005, the pt's sister developed a case of breakthrough (WAES0602USA00431). The physician believed that the sister gave it to the pt, who also developed a case of varicella in Nov 2005. It was unk how many lesions the pt had or if fever was present. Unspecified medical attention was sought. The pt subsequently recovered. A product quality complaint was not involved. Additional information has been requested.
This is a spontaneous report from a contactable nurse. A child male patient of an unspecified ethnicity received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunisation. The patient medical history was not reported. The patient received concomitantly two other unspecified vaccines. The patient experienced eczema flare up on an unspecified date with outcome of unknown. The information on the batch number has been requested.
Fever, body aches, congestion, sore throat, cough, nausea, vomiting
This medically confirmed spontaneous report (initial receipt 07-NOV-2014) concerns a 16 year old female patient. On 15-OCT-2014, the patient inadvertently received intradermal AFLURIA (batch number: 09749211A), 0.1 ml, when the nurse thought that she was administering a TB skin test. On 22-OCT-2014, the patient received remaining 0.4 ml dose of AFLURIA intramuscularly. No adverse event was reported. Outcome was reported as recovered.
Headache  - which felt like the top of my head was going to blow off oThroat closing up  had trouble breathing  oChest very tight, sore, and heavy  wheezing o I was SO cold that I shook all over, including my teeth chattering.  I had three blankets on me, one of which was an electric blanket on its highest setting and a heating pad (on my chest) on its highest setting.  The shaking and chattering and pain all over my body lasted for about three hours. oEvery part of my body hurt.  Even my skin hurt with any kind of contact  including the  blankets.  I do not believe I had a fever. oI had cramps in my right foot and left calf.
Tenderness in back and under left breast; two spots that look like insect bites (pt reports that it doesn't appear like a rash) could be varicella-related rash.
Information has been received from a lawyer regarding a case in litigation a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On an unknown date in 2014, the patient was vaccinated with ZOSTAVAX as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, anatomical location, lot#, expiration date were unknown). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles (onset date was not provided). On an unknown date in 2016, the patient was treated by the physician for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. The reporter determined the events to be related to the ZOSTAVAX.
Lips began to swell, bleed, and itch. Was prescribed Aquaphor and Prednisone and advised to get an over the counter antihistamine by healthcare professional.
After approximately 15 min the patient reported feeling fatigued , patient denies shortness of breath, skin is warm and dry to touch .Patient heart and lung sounds are normal to ascultation and reports no additional symptoms. In fact patient reports to feeling back to baseline. B/P 136/78 Heart Rate 97 SPO2 94% Consulted with MD who was agreeable to sending the pate int home without intervention. Vitals 1318 B/P 114/77 Heart Rate 90 SPO2 94% Patient discharged to home and will call our office with any additional questions or concerns. Also instructed to call 911 for any emergent issues.
Nurse administered the wrong vaccine. I was to get annual TB test and the nurse injected T-dap in error. Red, not, sore, swollen spot on forearm - increasing in size and hurts.